Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 3Neoplasms 2NSCLC 2Thoracic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Recurrence 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Neoplasms by Site 1Lung Diseases 1Carcinoma, Renal Cell 1Carcinoma, Bronchogenic 1Brain Neoplasms 1Asymptomatic Brain Metastases 1

Interventions

Tyrosine Kinase Inhibitors 1Surgical Procedures, Operative 1Pemetrexed 1One-Lung Ventilation 1Mitozytrex 1Mitomycin 1Iodized Oil 1Imatinib Mesylate 1Ethiodized Oil 1Drug Delivery Systems 1Doxycycline 1Diclofenac 1Dasatinib 1Cryotherapy 1Control Groups 1Cisplatin 1Catheters, Indwelling 1Blood Specimen Collection 1Anesthesia, General 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleural Neoplasms × Tyrosine Kinase Inhibitors × Thoracic × Clear all
NCT01999985 2020-11-27

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
25 enrolled 10 charts
Thoracic

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Pleural Diseases, Pleural Effusion, Pleural Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡